Sudie E. Back

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
Suite 151
Charleston Center - 5 Charleston Center Drive, Cha
Phone843-792-9383
Fax843-792-3514
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Back's primary research focus is the treatment of substance use disorders (SUD) and co-occurring post-traumatic stress disorder (PTSD). She leads a variety of studies to examine SUD and PTSD, including randomized controlled trials of behavioral as well as pharmacologic interventions, laboratory-based investigations, and neuroimaging studies. She has received funding from the National Institute of Drug Abuse (NIDA), the Department of Defense and smaller foundations.
    Collapse keywords
    Military, Psychiatry, Alcohol, Anxiety, Substance Use, Drug Studies, Mental Health, Stress Disorders

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Flanagan JC, Nietert PJ, Sippel L, Jarnecke AM, Kirby C, Hogan JN, Massa AA, Brower J, Back SE, Parrott D. A randomized controlled trial examining the effects of intranasal oxytocin on alcohol craving and intimate partner aggression among couples. J Psychiatr Res. 2022 08; 152:14-24. PMID: 35709548.
      Citations:    
    2. Back SE, Acierno R, Saraiya TC, Harley B, Wangelin B, Jarnecke AM, McTeague LM, Brown DG, Ana ES, Rothbaum AO, Adams RJ. Enhancing Prolonged Exposure therapy for PTSD using physiological biomarker-driven technology. Contemp Clin Trials Commun. 2022 Aug; 28:100940. PMID: 35664505.
      Citations:    
    3. Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA. Correction to: The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs. 2022 May; 36(5):553. PMID: 35482175.
      Citations:    
    4. Jarnecke AM, Saraiya TC, Brown DG, Richardson J, Killeen T, Back SE. Examining the role of social support in treatment for co-occurring substance use disorder and posttraumatic stress disorder. Addict Behav Rep. 2022 Jun; 15:100427. PMID: 35480064.
      Citations:    
    5. Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs. 2022 05; 36(5):451-482. PMID: 35316513.
      Citations:    
    6. Morgan-López AA, Hien DA, Saraiya TC, Saavedra LM, Norman SB, Killeen TK, Simpson TL, Fitzpatrick S, Mills KL, Ruglass LM, Back SE, López-Castro T. Estimating posttraumatic stress disorder severity in the presence of differential item functioning across populations, comorbidities, and interview measures: Introduction to Project Harmony. J Trauma Stress. 2022 06; 35(3):926-940. PMID: 35124864.
      Citations:    
    7. Jones JL, Barth KS, Brown DG, Halliday CA, Brady KT, Book SW, Bristol EJ, Back SE. The Drug Abuse Research Training (DART) Program for Psychiatry Residents and Summer Fellows: 15-Year Outcomes. Acad Psychiatry. 2022 Jun; 46(3):317-324. PMID: 35113391.
      Citations:    
    8. Saraiya TC, Badour CL, Jones AC, Jarnecke AM, Brown DG, Flanagan JC, Killeen TK, Back SE. The role of posttraumatic guilt and anger in integrated treatment for PTSD and co-occurring substance use disorders among primarily male veterans. Psychol Trauma. 2022 Jan 13. PMID: 35025558.
      Citations:    
    9. Gandelman EM, Miller SA, Back SE. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness. J Trauma Stress. 2022 04; 35(2):682-693. PMID: 34979039.
      Citations:    
    10. Hien DA, Fitzpatrick S, Saavedra LM, Ebrahimi CT, Norman SB, Tripp J, Ruglass LM, Lopez-Castro T, Killeen TK, Back SE, Morgan-López AA. What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders. Eur J Psychotraumatol. 2022; 13(1):2001191. PMID: 34992759.
      Citations:    
    11. Badour CL, Flanagan JC, Allan NP, Gilmore AK, Gros DF, Killeen T, Korte KJ, Brown DG, Kolnogorova K, Back SE. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2022 04; 35(2):546-558. PMID: 34773928.
      Citations:    
    12. Hahn CK, Jarnecke AM, Calhoun C, Melkonian A, Flanagan JC, Back SE. Sexual Harassment and Assault During Deployment: Associations with Treatment Outcomes Among Veterans with Co-occurring PTSD and SUD. Mil Psychol. 2022; 34(1):12-22. PMID: 35340543.
      Citations:    
    13. Peterson AL, Young-McCaughan S, Roache JD, Mintz J, Litz BT, Williamson DE, Resick PA, Foa EB, McGeary DD, Dondanville KA, Taylor DJ, Wachen JS, Fox PT, Bryan CJ, McLean CP, Pruiksma KE, Yarvis JS, Niles BL, Abdallah CG, Averill LA, Back SE, Baker MT, Blount TH, Borah AM, Borah EV, Brock MS, Brown LA, Burg MM, Cigrang JA, DeBeer BB, DeVoe ER, Fina BA, Flanagan JC, Fredman SJ, Gardner CL, Gatchel RR, Goodie JL, Gueorguieva R, Higgs JB, Jacoby VM, Kelly KM, Krystal JH, Lapiz-Bluhm MD, López-Roca AL, Marx BP, Maurer DM, McDevitt-Murphy ME, McGeary CA, Meyer EC, Miles SR, Monson CM, Morilak DA, Moring JC, Mysliwiec V, Nicholson KL, Rauch SAM, Riggs DS, Rosen CS, Rudd MD, Schobitz RP, Schrader CC, Shinn AM, Shiroma PR, Sloan DM, Stern SL, Strong R, Vannoy SD, Young KA, Keane TM. STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations. Contemp Clin Trials. 2021 11; 110:106583. PMID: 34600107.
      Citations:    
    14. Henschel AV, Flanagan JC, Augur IF, Jeffirs SM, Back SE. Motives for prescription opioid use: The role of alexithymia and distress tolerance. Am J Addict. 2022 01; 31(1):55-60. PMID: 34570408.
      Citations:    
    15. Crum KI, Flanagan JC, Vaughan B, Aloi J, Moran-Santa Maria MM, Back SE, Brady KT, Joseph JE. Oxytocin, PTSD, and sexual abuse are associated with attention network intrinsic functional connectivity. Psychiatry Res Neuroimaging. 2021 10 30; 316:111345. PMID: 34371478.
      Citations:    
    16. McLean CP, Back SE, Capone C, Morland L, Norman SB, Rauch SAM, Schnurr PP, Teng E, Acierno R. The Impact of COVID-19 on Psychotherapy Participation Among Individuals With Posttraumatic Stress Disorder Enrolled in Treatment Research. J Trauma Stress. 2022 02; 35(1):308-313. PMID: 34291832.
      Citations:    
    17. Melkonian AJ, Flanagan JC, Calhoun CD, Hogan JN, Back SE. Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder. J Clin Psychopharmacol. 2021 Jul-Aug 01; 41(4):465-469. PMID: 34121063.
      Citations:    
    18. Saavedra LM, Morgan-López AA, Hien DA, López-Castro T, Ruglass LM, Back SE, Fitzpatrick S, Norman SB, Killeen TK, Ebrahimi CT, Hamblen J. Evaluating treatments for posttraumatic stress disorder, alcohol and other drug use disorders using meta-analysis of individual patient data: Design and methodology of a virtual clinical trial. Contemp Clin Trials. 2021 08; 107:106479. PMID: 34157418.
      Citations:    
    19. Fitzpatrick SS, Morgan-López AA, Saraiya TC, Back SE, Killeen TK, Norman SB, López-Castro T, Ruglass LM, Saavedra LM, Hien DA. Graded response item response theory in scaling suicidal thoughts and behaviors among trauma-exposed women with substance use disorders. Psychol Addict Behav. 2022 Jun; 36(4):397-409. PMID: 34138594.
      Citations:    
    20. Saraiya TC, Jarnecke AM, Jones J, Brown DG, Brady KT, Back SE. Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder. Drug Alcohol Depend. 2021 08 01; 225:108755. PMID: 34052686.
      Citations:    
    21. Kline AC, Panza KE, Harlé KM, Angkaw AC, Trim RS, Back SE, Norman SB. Within-treatment clinical markers of dropout risk in integrated treatments for comorbid PTSD and alcohol use disorder. Drug Alcohol Depend. 2021 04 01; 221:108592. PMID: 33618193.
      Citations:    
    22. Lozano BE, Allan NP, Gros DF, Jones J, Back SE. Treatment Goals and Alcohol Use Outcomes in Veterans With Comorbid Alcohol Dependence and Posttraumatic Stress Disorder. Am J Addict. 2021 03; 30(2):131-137. PMID: 33289961.
      Citations:    
    23. Mills KL, Barrett E, Back SE, Cobham VE, Bendall S, Perrin S, Brady KT, Ross J, Peach N, Kihas I, Cassar J, Schollar-Root O, Teesson M. Randomised controlled trial of integrated trauma-focused psychotherapy for traumatic stress and substance use among adolescents: trial protocol. BMJ Open. 2020 11 30; 10(11):e043742. PMID: 33257495.
      Citations:    
    24. Saavedra LM, Morgan-López AA, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, Lopez-Castro T. Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 04; 34(2):454-466. PMID: 33175470.
      Citations:    
    25. Brown DG, Flanagan JC, Jarnecke A, Killeen TK, Back SE. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment. J Ethn Subst Abuse. 2022 Jul-Sep; 21(3):1141-1164. PMID: 33111647.
      Citations:    
    26. Ruglass LM, Morgan-López AA, Saavedra LM, Hien DA, Fitzpatrick S, Killeen TK, Back SE, López-Castro T. Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychol Assess. 2020 Nov; 32(11):1015-1027. PMID: 32853005.
      Citations:    
    27. Maier A, Dharan A, Oliver G, Berk M, Redston S, Back SE, Kalivas P, Ng C, Kanaan RA. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol. BMC Psychiatry. 2020 08 06; 20(1):397. PMID: 32762663.
      Citations:    
    28. Flanagan JC, Mitchell JM, Baker NL, Woolley J, Wangelin B, Back SE, McQuaid JR, Neylan TC, Wolfe WR, Brady KT. Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial. Contemp Clin Trials. 2020 08; 95:106074. PMID: 32561468.
      Citations:    
    29. Morgan-López AA, Killeen TK, Saavedra LM, Hien DA, Fitzpatrick S, Ruglass LM, Back SE. Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD. J Affect Disord. 2020 09 01; 274:832-840. PMID: 32664022.
      Citations:    
    30. Teeters JB, Jones JL, Jarnecke AM, Back SE. Sleep moderates the relationship between stress and craving in individuals with opioid use disorder. Exp Clin Psychopharmacol. 2021 Aug; 29(4):418-426. PMID: 32297784.
      Citations:    
    31. Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE, Prisciandaro J, Killeen T, Brown DG, Taimina L, Compean E, Malcolm R, Flanagan JC, Kalivas PW. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961. PMID: 32087337.
      Citations:    
    32. Morgan-López AA, Saavedra LM, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, López-Castro T, Patock-Peckham JA. Estimation of equable scale scores and treatment outcomes from patient- and clinician-reported PTSD measures using item response theory calibration. Psychol Assess. 2020 Apr; 32(4):321-335. PMID: 31804102.
      Citations:    
    33. Leone RM, Jarnecke AM, Back SE, Brady KT, Flanagan JC. The moderating role of infidelity on the relation between oxytocin and conflict behaviors among substance misusing couples. Exp Clin Psychopharmacol. 2020 Jun; 28(3):251-257. PMID: 31556677.
      Citations:    
    34. Flanagan JC, Joseph JE, Nietert PJ, Back SE, McCrady BS. Design of a randomized controlled trial examining the efficacy of oxytocin to enhance alcohol behavioral couple therapy. Contemp Clin Trials. 2019 07; 82:1-8. PMID: 31063869.
      Citations:    
    35. Dowdle LT, Borckardt JJ, Back SE, Morgan K, Adams D, Madan A, Balliet W, Hanlon CA. Sensitized brain response to acute pain in patients using prescription opiates for chronic pain: A pilot study. Drug Alcohol Depend. 2019 07 01; 200:6-13. PMID: 31071496.
      Citations:    
    36. Lancaster CL, Gros DF, Mullarkey MC, Badour CL, Killeen TK, Brady KT, Back SE. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behav Cogn Psychother. 2020 Jan; 48(1):38-53. PMID: 31010449.
      Citations:    
    37. Jeffirs SM, Jarnecke AM, Flanagan JC, Killeen TK, Laffey TF, Back SE. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 06 01; 199:70-75. PMID: 31009834.
      Citations:    
    38. Gilmore AK, Guille C, Baker NL, Brady KT, Hahn CK, Davis CM, McCauley JL, Back SE. Gender differences in subjective stress and neuroendocrine response to a stress task among individuals with opioid dependence: A pilot study. Addict Behav. 2019 05; 92:148-154. PMID: 30640146.
      Citations:    
    39. Szafranski DD, Gros DF, Acierno R, Brady KT, Killeen TK, Back SE. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters. Clin Psychol Psychother. 2019 Mar; 26(2):218-226. PMID: 30419153.
      Citations:    
    40. Flanagan JC, Yonce S, Calhoun CD, Back SE, Brady KT, Joseph JE. Preliminary development of a neuroimaging paradigm to examine neural correlates of relationship conflict. Psychiatry Res Neuroimaging. 2019 01 30; 283:125-134. PMID: 30581042.
      Citations:    
    41. Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 03; 90:369-377. PMID: 30529244.
      Citations:    
    42. Flanagan JC, Allan NP, Calhoun CD, Badour CL, Moran-Santa Maria M, Brady KT, Back SE. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder. Exp Clin Psychopharmacol. 2019 Feb; 27(1):45-54. PMID: 30382728.
      Citations:    
    43. Jarnecke AM, Allan NP, Badour CL, Flanagan JC, Killeen TK, Back SE. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 03; 90:35-39. PMID: 30355535.
      Citations:    
    44. Jarnecke AM, Barden E, Back SE, Brady KT, Flanagan JC. Intimate partner violence moderates the association between oxytocin and reactivity to dyadic conflict among couples. Psychiatry Res. 2018 12; 270:404-411. PMID: 30308464.
      Citations:    
    45. Back SE, Flanagan JC, Jones JL, Augur I, Peterson AL, Young-McCaughan S, Shirley DW, Henschel A, Joseph JE, Litz BT, Hancock AK, Roache JD, Mintz J, Wachen JS, Keane TM, Brady KT. Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans. Contemp Clin Trials. 2018 10; 73:8-15. PMID: 30145268.
      Citations:    
    46. Morley KC, Baillie A, Van Den Brink W, Chitty KE, Brady K, Back SE, Seth D, Sutherland G, Leggio L, Haber PS. N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research. Expert Opin Investig Drugs. 2018 08; 27(8):667-675. PMID: 30019966.
      Citations:    
    47. Jones JL, Mateus CF, Malcolm RJ, Brady KT, Back SE. Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review. Front Psychiatry. 2018; 9:277. PMID: 30140240.
      Citations:    
    48. Gilmore AK, Jones JL, Moreland AD, Hahn CK, Brady KT, Back SE. Gender moderates the association between distress tolerance and alcohol use among individuals with opioid use disorder. Drug Alcohol Depend. 2018 09 01; 190:9-12. PMID: 29960920.
      Citations:    
    49. Tomko RL, Jones JL, Gilmore AK, Brady KT, Back SE, Gray KM. N-acetylcysteine: A potential treatment for substance use disorders. Curr Psychiatr. 2018 06; 17(6):30-36, 41-42, 55. PMID: 30016376.
      Citations:    
    50. Solomon DT, Nietert PJ, Calhoun C, Smith DW, Back SE, Barden E, Brady KT, Flanagan JC. Effects of Oxytocin on Emotional and Physiological Responses to Conflict in Couples with Substance Misuse. Couple Family Psychol. 2018 Jun; 7(2):91-102. PMID: 30740265.
      Citations:    
    51. Back SE, Jones JL. Alcohol Use Disorder and Posttraumatic Stress Disorder: An Introduction. Alcohol Clin Exp Res. 2018 05; 42(5):836-840. PMID: 29489019.
      Citations:    
    52. Flanagan JC, Jones JL, Jarnecke AM, Back SE. Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018; 39(2):181-192. PMID: 31198657.
      Citations:    
    53. Flanagan JC, Sippel LM, Wahlquist A, Moran-Santa Maria MM, Back SE. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 03; 98:64-69. PMID: 29294429.
      Citations:    
    54. Flanagan JC, Fischer MS, Nietert PJ, Back SE, Maria MM, Snead A, Brady KT. Effects of oxytocin on cortisol reactivity and conflict resolution behaviors among couples with substance misuse. Psychiatry Res. 2018 02; 260:346-352. PMID: 29232576.
      Citations:    
    55. Campbell ANC, Back SE, Ostroff JS, Hien DA, Gourevitch MN, Sheffer CE, Brady KT, Hanley K, Bereket S, Book S. Addiction Research Training Programs: Four Case Studies and Recommendations for Evaluation. J Addict Med. 2017 Sep/Oct; 11(5):333-338. PMID: 28590393.
      Citations:    
    56. Teeters JB, Lancaster CL, Brown DG, Back SE. Substance use disorders in military veterans: prevalence and treatment challenges. Subst Abuse Rehabil. 2017; 8:69-77. PMID: 28919834.
      Citations:    
    57. Bountress KE, Badour C, Flanagan J, Gilmore AK, Back SE. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes? Psychol Trauma. 2018 Nov; 10(6):662-665. PMID: 28771018.
      Citations:    
    58. Gros DF, Lancaster CL, Horner MD, Szafranski DD, Back SE. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans. Compr Psychiatry. 2017 10; 78:48-53. PMID: 28803041.
      Citations:    
    59. Flanagan JC, Fischer MS, Badour CL, Ornan G, Killeen TK, Back SE. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218. PMID: 28541802.
      Citations:    
    60. Ruglass LM, Lopez-Castro T, Papini S, Killeen T, Back SE, Hien DA. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161. PMID: 28490022.
      Citations:    
    61. Szafranski DD, Snead A, Allan NP, Gros DF, Killeen T, Flanagan J, Pericot-Valverde I, Back SE. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35. PMID: 28460246.
      Citations:    
    62. Mills AC, Badour CL, Korte KJ, Killeen TK, Henschel AV, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length. J Trauma Stress. 2017 04; 30(2):166-172. PMID: 28329434.
      Citations:    
    63. Badour CL, Flanagan JC, Gros DF, Killeen T, Pericot-Valverde I, Korte KJ, Allan NP, Back SE. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281. PMID: 28221062.
      Citations:    
    64. Persson A, Back SE, Killeen TK, Brady KT, Schwandt ML, Heilig M, Magnusson Å. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women. J Addict Med. 2017 Mar/Apr; 11(2):119-125. PMID: 28079572.
      Citations:    
    65. Jaconis M, Santa Ana EJ, Killeen TK, Badour CL, Back SE. Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran. Am J Addict. 2017 Mar; 26(2):112-114. PMID: 28118514.
      Citations:    
    66. Korte KJ, Bountress KE, Tomko RL, Killeen T, Moran-Santa Maria M, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: The Mediating Role of PTSD Improvement in the Reduction of Depression. J Clin Med. 2017 Jan 13; 6(1). PMID: 28098747.
      Citations:    
    67. Lancaster CL, Teeters JB, Gros DF, Back SE. Posttraumatic Stress Disorder: Overview of Evidence-Based Assessment and Treatment. J Clin Med. 2016 Nov 22; 5(11). PMID: 27879650.
      Citations:    
    68. Mills KL, Barrett EL, Merz S, Rosenfeld J, Ewer PL, Sannibale C, Baker AL, Hopwood S, Back SE, Brady KT, Teesson M. Integrated Exposure-Based Therapy for Co-Occurring Post Traumatic Stress Disorder (PTSD) and Substance Dependence: Predictors of Change in PTSD Symptom Severity. J Clin Med. 2016 Nov 15; 5(11). PMID: 27854264.
      Citations:    
    69. Back SE, McCauley JL, Korte KJ, Gros DF, Leavitt V, Gray KM, Hamner MB, DeSantis SM, Malcolm R, Brady KT, Kalivas PW. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446. PMID: 27736051.
      Citations:    
    70. Gros DF, Flanagan JC, Korte KJ, Mills AC, Brady KT, Back SE. Relations among social support, PTSD symptoms, and substance use in veterans. Psychol Addict Behav. 2016 Nov; 30(7):764-770. PMID: 27786511.
      Citations:    
    71. Williams EM, Lorig K, Glover S, Kamen D, Back S, Merchant A, Zhang J, Oates JC. Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans. BMC Health Serv Res. 2016 08 02; 16(a):339. PMID: 27485509.
      Citations:    
    72. Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent Treatment of Substance Use and PTSD. Curr Psychiatry Rep. 2016 08; 18(8):70. PMID: 27278509.
      Citations:    
    73. Adams ZW, McCauley JL, Back SE, Flanagan JC, Hanson RF, Killeen TK, Danielson CK. Clinician Perspectives on Treating Adolescents with Co-occurring Post-Traumatic Stress Disorder, Substance Use, and Other Problems. J Child Adolesc Subst Abuse. 2016; 25(6):575-583. PMID: 27840568.
      Citations:    
    74. Flanagan JC, Hakes JK, McClure EA, Snead AL, Back SE. Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. Am J Addict. 2016 06; 25(4):283-90. PMID: 27196699.
      Citations:    
    75. Back SE, Gros DF, Price M, LaRowe S, Flanagan J, Brady KT, Davis C, Jaconis M, McCauley JL. Laboratory-induced stress and craving among individuals with prescription opioid dependence. Drug Alcohol Depend. 2015 Oct 01; 155:60-7. PMID: 26342626.
      Citations:    
    76. Lozano BE, Gros DF, Killeen T, Jaconis M, Beylotte FM, Boyd S, Back SE. To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD. Am J Addict. 2015 Oct; 24(7):578-81. PMID: 26300219.
      Citations:    
    77. Jobe-Shields L, Flanagan JC, Killeen T, Back SE. Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23. PMID: 26132535.
      Citations:    
    78. Bentzley BS, Barth KS, Back SE, Aronson G, Book SW. Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. J Subst Abuse Treat. 2015 Sep; 56:48-53. PMID: 25899872.
      Citations:    
    79. Killeen TK, Back SE, Brady KT. Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug Alcohol Rev. 2015 May; 34(3):234-41. PMID: 25737377.
      Citations:    
    80. Merghati-Khoei E, Rimaz S, Korte JE, Back SE, Brady KT, Abad M, Shamsalizadeh N. Intimate partner violence and risky sexual behaviors among Iranian women with substance use disorders. Med J Islam Repub Iran. 2015; 29:174. PMID: 26034727.
      Citations:    
    81. Bentzley BS, Barth KS, Back SE, Book SW. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat. 2015 May; 52:48-57. PMID: 25601365.
      Citations:    
    82. McCauley JL, Mercer MA, Barth KS, Brady KT, Back SE. Pain management perceptions among prescription opioid dependent individuals. Drug Alcohol Depend. 2014 Sep 01; 142:354-8. PMID: 25034899.
      Citations:    
    83. Hartwell EE, Pfeifer JG, McCauley JL, Moran-Santa Maria M, Back SE. Sleep disturbances and pain among individuals with prescription opioid dependence. Addict Behav. 2014 Oct; 39(10):1537-42. PMID: 24999989.
      Citations:    
    84. Back SE, Gros DF, McCauley JL, Flanagan JC, Cox E, Barth KS, Brady KT. Laboratory-induced cue reactivity among individuals with prescription opioid dependence. Addict Behav. 2014 Aug; 39(8):1217-23. PMID: 24813546.
      Citations:    
    85. Cluver J, Book S, Brady K, Back S, Thornley N. Engaging medical students in research: reaching out to the next generation of physician-scientists. Acad Psychiatry. 2014 Jun; 38(3):345-9. PMID: 24913099.
      Citations:    
    86. Flanagan JC, Teer A, Beylotte FM, Killeen TK, Back SE. Correlates of Recent and Lifetime Aggression among Veterans with Co-Occurring PTSD and Substance Use Disorders. Ment Health Subst Use. 2014; 7(4):315-328. PMID: 25419233.
      Citations:    
    87. Back SE, Killeen TK, Teer AP, Hartwell EE, Federline A, Beylotte F, Cox E. Substance use disorders and PTSD: an exploratory study of treatment preferences among military veterans. Addict Behav. 2014 Feb; 39(2):369-73. PMID: 24199930.
      Citations:    
    88. Barth KS, Maria MM, Lawson K, Shaftman S, Brady KT, Back SE. Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence. Am J Addict. 2013 Sep-Oct; 22(5):486-91. PMID: 23952895.
      Citations:    
    89. Gros DF, Milanak ME, Brady KT, Back SE. Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence. Am J Addict. 2013 May-Jun; 22(3):261-5. PMID: 23617869.
      Citations:    
    90. Lawson KM, Back SE, Hartwell KJ, Moran-Santa Maria M, Brady KT. A comparison of trauma profiles among individuals with prescription opioid, nicotine, or cocaine dependence. Am J Addict. 2013 Mar-Apr; 22(2):127-31. PMID: 23414497.
      Citations:    
    91. McCauley JL, Back SE, Brady KT. Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids. Addict Behav. 2013 Jun; 38(6):2230-5. PMID: 23501140.
      Citations:    
    92. McCauley JL, Killeen T, Gros DF, Brady KT, Back SE. Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment. Clin Psychol (New York). 2012 Sep 01; 19(3). PMID: 24179316.
      Citations:    
    93. Mills KL, Teesson M, Back SE, Brady KT, Baker AL, Hopwood S, Sannibale C, Barrett EL, Merz S, Rosenfeld J, Ewer PL. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15; 308(7):690-9. PMID: 22893166.
      Citations:    
    94. Back SE, Killeen T, Foa EB, Santa Ana EJ, Gros DF, Brady KT. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. Am J Psychiatry. 2012 Jul; 169(7):688-91. PMID: 22760188.
      Citations:    
    95. Hartwell KJ, Back SE, McRae-Clark AL, Shaftman SR, Brady KT. Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals. Addict Behav. 2012 Apr; 37(4):373-8. PMID: 22284583.
      Citations:    
    96. Farrugia PL, Mills KL, Barrett E, Back SE, Teesson M, Baker A, Sannibale C, Hopwood S, Rosenfeld J, Merz S, Brady KT. Childhood trauma among individuals with co-morbid substance use and post traumatic stress disorder. Ment Health Subst Use. 2011 Nov; 4(4):314-326. PMID: 21984884.
      Citations:    
    97. Killeen TK, Back SE, Brady KT. The Use of Exposure-Based Treatment Among Individuals With PTSD and Co-occurring Substance Use Disorders: Clinical Considerations. J Dual Diagn. 2011 Oct 01; 7(4):194-206. PMID: 23662094.
      Citations:    
    98. Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):313-23. PMID: 21854273.
      Citations:    
    99. Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64. PMID: 21802222.
      Citations:    
    100. Back SE, Lawson KM, Singleton LM, Brady KT. Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav. 2011 Aug; 36(8):829-34. PMID: 21514061.
      Citations:    
    101. DeSantis SM, Baker NL, Back SE, Spratt E, Ciolino JD, Moran-Santa Maria M, Dipankar B, Brady KT. Gender differences in the effect of early life trauma on hypothalamic-pituitary-adrenal axis functioning. Depress Anxiety. 2011 May; 28(5):383-92. PMID: 21328636.
      Citations:    
    102. Back SE, Book SW, Santos AB, Brady KT. Training physician-scientists: a model for integrating research into psychiatric residency. Acad Psychiatry. 2011 Jan-Feb; 35(1):40-5. PMID: 21209406.
      Citations:    
    103. Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav. 2010 Nov; 35(11):1001-7. PMID: 20598809.
      Citations:    
    104. Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010 Jun; 33(2):339-55. PMID: 20385341.
      Citations:    
    105. Moran-Santa Maria MM, McRae-Clark AL, Back SE, DeSantis SM, Baker NL, Spratt EG, Simpson AN, Brady KT. Influence of cocaine dependence and early life stress on pituitary-adrenal axis responses to CRH and the Trier social stressor. Psychoneuroendocrinology. 2010 Nov; 35(10):1492-500. PMID: 20570051.
      Citations:    
    106. Back SE. Toward an improved model of treating co-occurring PTSD and substance use disorders. Am J Psychiatry. 2010 Jan; 167(1):11-3. PMID: 20068121.
      Citations:    
    107. Waldrop AE, Price KL, Desantis SM, Simpson AN, Back SE, McRae AL, Spratt EG, Kreek MJ, Brady KT. Community-dwelling cocaine-dependent men and women respond differently to social stressors versus cocaine cues. Psychoneuroendocrinology. 2010 Jul; 35(6):798-806. PMID: 20004523.
      Citations:    
    108. Brady KT, Tuerk P, Back SE, Saladin ME, Waldrop AE, Myrick H. Combat posttraumatic stress disorder, substance use disorders, and traumatic brain injury. J Addict Med. 2009 Dec; 3(4):179-88. PMID: 21769015.
      Citations:    
    109. Banna KM, Back SE, Do P, See RE. Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats. Behav Brain Res. 2010 Mar 17; 208(1):144-8. PMID: 19931573.
      Citations:    
    110. Back SE, Hartwell K, DeSantis SM, Saladin M, McRae-Clark AL, Price KL, Moran-Santa Maria MM, Baker NL, Spratt E, Kreek MJ, Brady KT. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend. 2010 Jan 01; 106(1):21-7. PMID: 19726138.
      Citations:    
    111. DeSantis SM, Bandyopadhyay D, Back SE, Brady KT. Non-treatment laboratory stress- and cue-reactivity studies are associated with decreased substance use among drug-dependent individuals. Drug Alcohol Depend. 2009 Dec 01; 105(3):227-33. PMID: 19717245.
      Citations:    
    112. Back SE, Payne RA, Waldrop AE, Smith A, Reeves S, Brady KT. Prescription opioid aberrant behaviors: a pilot study of sex differences. Clin J Pain. 2009 Jul-Aug; 25(6):477-84. PMID: 19542794.
      Citations:    
    113. Payne RA, Back SE, Wright T, Hartwell K, Brady KT. Alcohol dependence in women: Comorbidities can complicate treatment. Curr Psychiatr. 2009 Jun 01; 8(6):52-59. PMID: 20676219.
      Citations:    
    114. Price KL, McRae-Clark AL, Saladin ME, Maria MM, DeSantis SM, Back SE, Brady KT. D-cycloserine and cocaine cue reactivity: preliminary findings. Am J Drug Alcohol Abuse. 2009; 35(6):434-8. PMID: 20014913.
      Citations:    
    115. Spratt EG, Back SE, Yeatts SD, Simpson AN, McRae-Clark A, Moran-Santa Maria MM, Price KL, Hartwell KT, Brady KT. Relationship between child abuse and adult smoking. Int J Psychiatry Med. 2009; 39(4):417-26. PMID: 20391862.
      Citations:    
    116. Back SE, Waldrop AE, Brady KT. Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: clinicians' perspectives. Am J Addict. 2009 Jan-Feb; 18(1):15-20. PMID: 19219661.
      Citations:    
    117. Dempsey JP, Back SE, Waldrop AE, Jenkins L, Brady KT. The influence of monetary compensation on relapse among addicted participants: empirical vs. anecdotal evidence. Am J Addict. 2008 Nov-Dec; 17(6):488-90. PMID: 19034740.
      Citations:    
    118. Back SE, Brady KT. Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations. Psychiatr Ann. 2008 Nov; 38(11):724-729. PMID: 20717489.
      Citations:    
    119. Back SE, Waldrop AE, Saladin ME, Yeatts SD, Simpson A, McRae AL, Upadhyaya HP, Contini Sisson R, Spratt EG, Allen J, Kreek MJ, Brady KT. Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology. 2008 Jun; 33(5):560-8. PMID: 18321653.
      Citations:    
    120. Carter RE, Haynes LF, Back SE, Herrin AE, Brady KT, Leimberger JD, Sonne SC, Hubbard RL, Liepman MR. Improving the transition from residential to outpatient addiction treatment: gender differences in response to supportive telephone calls. Am J Drug Alcohol Abuse. 2008; 34(1):47-59. PMID: 18161643.
      Citations:    
    121. Back SE, Brady KT, Waldrop AE, Yeatts SD, McRae AL, Spratt E. Early life trauma and sensitivity to current life stressors in individuals with and without cocaine dependence. Am J Drug Alcohol Abuse. 2008; 34(4):389-96. PMID: 18584568.
      Citations:    
    122. Verduin ML, Payne RA, McRae AL, Back SE, Simpson SA, Sarang RY, Brady KT. Assessment of club drug use in a treatment-seeking sample of individuals with marijuana dependence. Am J Addict. 2007 Nov-Dec; 16(6):484-7. PMID: 18058415.
      Citations:    
    123. Back SE, Gentilin S, Brady KT. Cognitive-behavioral stress management for individuals with substance use disorders: a pilot study. J Nerv Ment Dis. 2007 Aug; 195(8):662-8. PMID: 17700298.
      Citations:    
    124. Waldrop AE, Back SE, Brady KT, Upadhyaya HP, McRae AL, Saladin ME. Daily stressor sensitivity, abuse effects, and cocaine use in cocaine dependence. Addict Behav. 2007 Dec; 32(12):3015-25. PMID: 17706887.
      Citations:    
    125. Back SE, Brady KT, Sonne SC, Verduin ML. Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis. 2006 Sep; 194(9):690-6. PMID: 16971821.
      Citations:    
    126. Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF, Randall PK. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol. 2006 Sep; 67(5):700-6. PMID: 16847538.
      Citations:    
    127. McRae AL, Saladin ME, Brady KT, Upadhyaya H, Back SE, Timmerman MA. Stress reactivity: biological and subjective responses to the cold pressor and Trier Social stressors. Hum Psychopharmacol. 2006 Aug; 21(6):377-85. PMID: 16915579.
      Citations:    
    128. Waldrop AE, Back SE, Verduin ML, Brady KT. Triggers for cocaine and alcohol use in the presence and absence of posttraumatic stress disorder. Addict Behav. 2007 Mar; 32(3):634-9. PMID: 16863682.
      Citations:    
    129. Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, Saladin ME, Randall PK. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res. 2006 Jun; 30(6):938-46. PMID: 16737451.
      Citations:    
    130. Santa Ana EJ, Saladin ME, Back SE, Waldrop AE, Spratt EG, McRae AL, LaRowe SD, Timmerman MA, Upadhyaya H, Brady KT. PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma. Psychoneuroendocrinology. 2006 May; 31(4):501-9. PMID: 16413134.
      Citations:    
    131. Back SE, Jackson JL, Sonne S, Brady KT. Alcohol dependence and posttraumatic stress disorder: differences in clinical presentation and response to cognitive-behavioral therapy by order of onset. J Subst Abuse Treat. 2005 Jul; 29(1):29-37. PMID: 15979529.
      Citations:    
    132. Back SE, Brady KT, Jaanimägi U, Jackson JL. Cocaine dependence and PTSD: a pilot study of symptom interplay and treatment preferences. Addict Behav. 2006 Feb; 31(2):351-4. PMID: 15951125.
      Citations:    
    133. Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar; 29(3):395-401. PMID: 15770115.
      Citations:    
    134. Back SE, Brady KT, Jackson JL, Salstrom S, Zinzow H. Gender differences in stress reactivity among cocaine-dependent individuals. Psychopharmacology (Berl). 2005 Jun; 180(1):169-76. PMID: 15682303.
      Citations:    
    135. Back SE, Jackson JL, Fitzgerald M, Shaffer A, Salstrom S, Osman MM. Child sexual and physical abuse among college students in Singapore and the United States. Child Abuse Negl. 2003 Nov; 27(11):1259-75. PMID: 14637301.
      Citations:    
    136. Sonne SC, Back SE, Diaz Zuniga C, Randall CL, Brady KT. Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder. Am J Addict. 2003 Oct-Dec; 12(5):412-23. PMID: 14660155.
      Citations:    
    137. Back SE, Sonne SC, Killeen T, Dansky BS, Brady KT. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89. PMID: 12731687.
      Citations:    
    138. Brady KT, Dansky BS, Back SE, Foa EB, Carroll KM. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat. 2001 Jul; 21(1):47-54. PMID: 11516926.
      Citations:    
    139. Back SE, Dansky BS, Carroll KM, Foa EB, Brady KT. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures. J Subst Abuse Treat. 2001 Jul; 21(1):35-45. PMID: 11516925.
      Citations:    
    140. Richardson J, Barkan S, Cohen M, Back S, FitzGerald G, Feldman J, Young M, Palacio H. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care. 2001; 32(4):93-111. PMID: 11451159.
      Citations:    
    141. Back S, Dansky BS, Coffey SF, Saladin ME, Sonne S, Brady KT. Cocaine dependence with and without post-traumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity. Am J Addict. 2000; 9(1):51-62. PMID: 10914293.
      Citations:    
    142. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 26337039.
      Citations:    
    143. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 26391835.
      Citations:    
    144. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 33239837.
      Citations:    
    145. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 35589850.
      Citations:    
    146. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 23584107.
      Citations:    
    147. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 19349312.
      Citations:    
    148. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 17964738.
      Citations:    
    149. Back S, Lips HM. Child sexual abuse: victim age, victim gender, and observer gender as factors contributing to attributions of responsibility. Child Abuse Negl. 1998 Dec; 22(12):1239-52. PMID: 9871785.
      Citations:    
    Back's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (314)
    Explore
    _
    Co-Authors (66)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _